EME - 13/50/12

Assessing the efficacy and safety of methotrexate vs ciclosporin in the treatment of severe atopic eczema in children: the TREatment of severe Atopic eczema in children Taskforce (TREAT) randomised controlled trial

Project title: Assessing the efficacy and safety of methotrexate vs ciclosporin in the treatment of severe atopic eczema in children: the TREatment of severe Atopic eczema in children Taskforce (TREAT) randomised controlled trial

Call to action: 13/50 13/50 Skin Disorders

Research type: Primary Research

Chief investigator: Professor Carsten Flohrorcid.org/0000-0003-4884-6286

Contractor: King's College London

Cost: £918,483.17

Co-investigators: Dr Ashley Jones, Dr Emma Wedgeworth, Dr Fiona Browne, Dr Nicola Harman, Dr Paula Beattie, Miss Mandy Wan, Professor Alan Irvine, Professor Leonie Taams, Professor Luke O'Neill, Professor Nicholas Webb, Professor Paula Williamson.

Started: May 2015 | Status: Research in progress

ISRCTN: 15837754

Links to project documentation

The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.